Last reviewed · How we verify

Sublingual Film for Dermatophagoides pteronyssinus

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. · Phase 2 active Biologic

Sublingual Film for Dermatophagoides pteronyssinus is a Biologic drug developed by Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.. It is currently in Phase 2 development.

At a glance

Generic nameSublingual Film for Dermatophagoides pteronyssinus
SponsorZhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
ModalityBiologic
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Sublingual Film for Dermatophagoides pteronyssinus

What is Sublingual Film for Dermatophagoides pteronyssinus?

Sublingual Film for Dermatophagoides pteronyssinus is a Biologic drug developed by Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd..

Who makes Sublingual Film for Dermatophagoides pteronyssinus?

Sublingual Film for Dermatophagoides pteronyssinus is developed by Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (see full Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. pipeline at /company/zhejiang-wolwo-bio-pharmaceutical-co-ltd).

What development phase is Sublingual Film for Dermatophagoides pteronyssinus in?

Sublingual Film for Dermatophagoides pteronyssinus is in Phase 2.

Related